Clinical Trial

A First-in-Human Phase 1 Single-Ascending Dose Study of ABCL575 in Healthy Participants

Name: A First-in-Human Phase 1 Single-Ascending Dose Study of ABCL575 in Healthy Participants — clinical trial record (NCT07108894)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study aims to assess the safety and tolerability of ABCL575 in healthy participants following single ascending dose (SAD), in comparison to a placebo

Protocol Amendment History 1 change

critical Trial status changed: Recruiting → Active, Not Recruiting 2026-06-17

Trial Details

NCT Number	NCT07108894
Lead Sponsor	AbCellera Biologics Inc.
Conditions	Healthy Volunteers
Enrollment	40 participants
Start Date	2025-07-25
Primary Completion	2027-04 (estimated)
Study Completion	2027-04 (estimated)
Updated on ClinicalTrials.gov	2026-06-16